Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.8M | 2 | 97.8% |
| Consulting Fee | $39,826 | 4 | 2.2% |
| Travel and Lodging | $1,005 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARIAD Pharmaceuticals, Inc. | $1.8M | 3 | $0 (2017) |
| The Medicines Company | $39,826 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $39,826 | 4 | The Medicines Company ($39,826) |
| 2017 | $1.8M | 3 | ARIAD Pharmaceuticals, Inc. ($1.8M) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2018 | The Medicines Company | — | Consulting Fee | Cash or cash equivalent | $138.60 | General |
| 11/02/2018 | The Medicines Company | — | Consulting Fee | Cash or cash equivalent | $19,375.00 | General |
| 08/17/2018 | The Medicines Company | — | Consulting Fee | Cash or cash equivalent | $14,812.00 | General |
| 04/24/2018 | The Medicines Company | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 04/21/2017 | ARIAD Pharmaceuticals, Inc. | Iclusig (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $17,500.00 | General |
| Category: Not Applicable | ||||||
| 02/21/2017 | ARIAD Pharmaceuticals, Inc. | Iclusig (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,756,550.00 | General |
| Category: Not Applicable | ||||||
| 01/13/2017 | ARIAD Pharmaceuticals, Inc. | Iclusig (Drug) | Travel and Lodging | Cash or cash equivalent | $1,004.64 | General |
| Category: Not Applicable | ||||||
About Dr. Sarah Schlesinger, M.D
Dr. Sarah Schlesinger, M.D is a Immunopathology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2009. The National Provider Identifier (NPI) number assigned to this provider is 1396983573.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Schlesinger, M.D has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $39,826 received in 2018. These payments were reported across 7 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.8M).
Practice Information
- Specialty Immunopathology
- Location New York, NY
- Active Since 01/27/2009
- Last Updated 01/27/2009
- Taxonomy Code 207ZI0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396983573
Products in Payments
- Iclusig (Drug) $1.8M
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.